As part of the Biosimilar Education Grant, GBMA Education will be engaged in conferences nationwide, and will coordinate events dedicated to biosimilar medicines. Please see further details below.

Global Biosimilars Week 16 - 20 November 2020. Thank you for engaging in conversation about biosimilar medicines

Global Biosimilars Week

16 - 20 November 2020

Building on the success of the 2020 ‘Biosimilar Awareness Week’, conducted earlier this year by GBMA Education, the international Generic and Biosimilar Medicines Association (IGBA) will be hosting a Global Biosimilars Week from 16 – 20 November

This globally aligned educational initiative will look to engage stakeholders across the world in an online conversation to raise awareness of biosimilar medicines.  We invite you to join us on the @BiosimilarsAu social channels throughout the week or for an international perspective, click the button below 

Past Events
Biosimilar Awareness Week

Help us raise awareness about biosimilar medicines

Biosimilar Awareness Week will take place from 25 - 29 May 2020.

In 2020, Biosimilar Awareness Week is an opportunity for healthcare professionals and the Australian public to engage in a conversation about biosimilar medicines and their role in supporting the future of sustainable healthcare for all Australians.

Throughout the week, GBMA Education will be calling on the support of the wider healthcare community to help us raise awareness about biosimilar medicines by sharing key facts and information on their social media channels.

Click here to view key facts about biosimilar medicines that you can post to your social media channels
#biosimilaraware #biosimilarawareness2020

Your Patients, Your Government Multidisciplinary Forum and Workshop

2 October 2019

GBMA Education is pleased to announce the Minister for Health, the Hon. Greg Hunt MP, will deliver the keynote address at GBMA Education’s ‘Your Patients, Your Government’ Multidisciplinary Forum and Workshop for biosimilar medicines.

Following the keynote address by Minister Hunt, healthcare leaders will facilitate solution-driven discussions around key recurring topics for biosimilar medicines that have been raised across the healthcare system. The three panels will cover:

  • Tracking and traceability, and pharmacovigilance
  • Patient-centric care and the ‘human factor’
  • Health economics and sustainability of the PBS.

The event provides a unique opportunity to bring together stakeholders from across the healthcare sector, exploring critical topics for biosimilar medicines and their role in supporting the future of sustainable healthcare in Australia. Panellists for the event include:

  • Ms Penny Shakespeare, Department of Health Deputy Secretary for Health Financing
  • Dr John Skerritt, Department of Health Deputy Secretary for Health Products Regulation
  • Prof Stephen Clarke, Medical oncologist at the Northern Cancer Institute and Royal North Shore Hospital, Director of Cancer Services at Northern Sydney Local Health District and Professor of Medicine at the University of Sydney
  • A/Prof Simone Strasser, President of the Gastroenterological Society of Australia (commencing October 2019)
  • A/Prof Andrew Miller, Immediate Past President of the Australasian College of Dermatologists
  • Dr Mona Marabani, Past President of the Australian Rheumatology Association and Co-Chair of the Biosimilars Working Group
  • Dr Simon Ghaly, Head of the Inflammatory Bowel Disease Service and Staff Specialist at St. Vincent’s Hospital and patient representative
  • Dr Harry Nespolon, President Royal Australian College of General Practitioners
  • A/Prof Michael Ward, Discipline Leader: Pharmacy Education, School of Pharmacy and Medical Sciences, University of South Australia
  • David Ford, Executive Director Pharmacy and Redevelopment, North East Health.
Biosimilar week

Biosimilar Week

April 29 – 3 May 2019

Supporting the future of sustainable healthcare through the appropriate use of biosimilar medicines.

Biosimilar Week will feature the launch of the Biosimilar Education Hub – an online platform designed to facilitate peer-to-peer information exchange between healthcare professionals surrounding biosimilar medicines through video interviews, case studies, literature reviews and updates.

Biosimilar Week is an integral component of a comprehensive 3-year education program focusing on the appropriate use of biosimilar medicines, developed collaboratively by experts across medical specialties, and the medicines industry. The Program is coordinated by GBMA Education and funded through the Biosimilar Educational Grant, announced in April 2018.

Biosimilar Week will commence with an official announcement from the Hon Greg Hunt, Minister for Health, highlighting the critical role that biosimilar medicines play in the future of a sustainable healthcare system in Australia.